

Health Library
October 10, 2025
Question on this topic? Get an instant answer from August.
Teplizumab ni umuti wandikirwa ugamije gutinda igihe indwara ya diyabete yo mu bwoko bwa 1 itangira mu bantu bafite ibyago byinshi byo kurwara iyo ndwara. Uyu muti ukoreshwa mu kurwanya ubudahangarwa bw'umubiri ukora ugenewe selile zidasanzwe z'ubudahangarwa bw'umubiri zagenewe kwibasira selile zikora insuline mu gice cyawe cy'umubiri gishinzwe imisemburo. Bitekereze nk'uburyo bwo gutuza ubudahangarwa bw'umubiri burenze urugero mbere y'uko butera kwangirika kutagaruka ku bushobozi bw'umubiri wawe bwo gukora insuline.
Teplizumab ni umuti wa monoclonal antibody wagenewe gukumira cyangwa gutinda diyabete yo mu bwoko bwa 1. Uyu muti ubarirwa mu cyiciro cy'imiti yitwa immunosuppressants, bivuze ko ihindura uburyo ubudahangarwa bw'umubiri wawe bukora. Uyu muti utangwa binyuze mu gutera urushinge mu urugingo rw'imitsi (IV), kimwe n'uko wakwakira amazi mu bitaro.
Uyu muti uhagarariye intambwe ikomeye mu gukumira diyabete kuko niwo muti wa mbere wemewe na FDA ushobora gutinda itangira rya diyabete yo mu bwoko bwa 1. Uyu muti ukora ugamije selile za CD3-positive T, selile z'ubudahangarwa bw'umubiri zibeshya zigatera igice cyawe cy'umubiri gishinzwe imisemburo mu diyabete yo mu bwoko bwa 1. Mu kugabanya by'agateganyo imikorere y'izi selile, teplizumab ifasha kubungabunga ubushobozi bw'umubiri wawe bwo gukora insuline.
Teplizumab ikoreshwa by'umwihariko mu gutinda itangira rya diyabete yo mu bwoko bwa 1 mu bantu bakuru n'abana bafite imyaka 8 cyangwa barenze. Ushobora kuba ukwiriye guhabwa uyu muti niba uri mu cyiciro cya 2 cya diyabete yo mu bwoko bwa 1, bivuze ko ufite imisemburo imwe n'imwe mu maraso yawe n'impinduka zimwe na zimwe mu isukari yo mu maraso, ariko ntukagire ibimenyetso byose bya diyabete.
Muganga wawe akenshi azagusaba gukoresha teplizumab niba ibizamini by'amaraso byerekana ko ufite udukorombya tubiri cyangwa twinshi twa diyabete kandi urugero rw'isukari mu maraso yawe rugaragaza ko ushobora kurwara diyabete ya 1 mu myaka mike iri imbere. Intego ni kugira icyo ukora mbere yuko ukeneye guterwa inshinge za insuline buri munsi, bikaguha igihe kinini umubiri wawe ukora insuline karemano.
Uyu muti ntukoreshwa mu kuvura abantu basanzwe barwaye diyabete ya 1 cyangwa diyabete ya 2. Ugenewe cyane cyane gukumira indwara ku bantu bafite ibyago byinshi batararwara iyi ndwara yose.
Teplizumab ikora igihe gito ihagarika igice cy'ubwirinzi bw'umubiri wawe gitera uturemangingo dukora insuline mu gice cy'umwijima wawe. Muri diyabete ya 1, ubwirinzi bw'umubiri wawe bwibeshya bukamena utwo turemangingo twiza nk'abantu b'abanyamahanga bukabatsemba. Uyu muti ukora nk'umusifuzi, ukagira icyo ukora kugira ngo uhagarike iyi ngaruka mbi y'ubwirinzi bw'umubiri.
Uyu muti wifatanya n'uturemangingo twihariye tw'ubwirinzi bw'umubiri twitwa T cells kandi bituma bidakora cyangwa se bikaba byapfa igihe gito. Ibi bituma umwijima wawe ugira amahirwe yo gukira no gukomeza gukora insuline igihe kirekire. Nubwo teplizumab ifatwa nk'umuti ukomeye uhagarika ubwirinzi bw'umubiri, ukoreshwa mu gihe gito cyo kuvura, ibi bifasha kugabanya ibyago by'igihe kirekire.
Ubushakashatsi bwerekana ko teplizumab ishobora gutinda gutangira kwa diyabete ya 1 kuva ku myaka ibiri, nubwo abantu bamwe bashobora kungukirwa igihe kirekire. Uyu muti mu by'ukuri ukugurira igihe cy'agaciro mbere yuko utangira kuvurwa na insuline.
Teplizumab itangwa nk'urushinge ruterwa mu urugero rw'imitsi mu gihe cy'iminota 30 rimwe ku munsi mu gihe cy'iminsi 14 ikurikirana. Uzahabwa ubu buvuzi ahantu hakorerwa ibikorwa by'ubuvuzi aho abaganga bashobora kugukurikiranira hafi. Uyu muti ntushobora gufatwa nk'ipilule cyangwa guterwa nk'urushinge rworoshye.
Mbere ya buri nshinge, abaganga bashobora kuguha imiti yo gufasha kwirinda ibibazo byatewe n'inshinge. Iyi miti ishobora kuba irimo imiti irwanya allergie, acetaminophen, cyangwa corticosteroids. Ntabwo bisaba kwiyiriza mbere yo kuvurwa, ariko ni byiza kurya ifunguro rito mbere kugira ngo wirinde kumva urujijo mu gihe cy'inshinge.
Mu gihe cy'inshinge, uraza gukurikiranwa kugira ngo urebe niba hari ingaruka cyangwa ibibazo byagaragara. Abaganga bazagenzura ibimenyetso byawe by'ingenzi buri gihe kandi barebe ibimenyetso nk'umuriro, imbeho, cyangwa guhumeka bigoranye. Abantu benshi bakira neza ubu buvuzi, ariko kuba hari abaganga hafi bituma umutekano wawe wose urindwa mu gihe cyose cy'ubuvuzi.
Uburyo busanzwe bwo kuvura na teplizumab ni iminsi 14 y'inshinge za buri munsi. Ubusanzwe ni uburyo bumwe bwo kuvura, bivuze ko ntuzasabwa kubisubiramo buri gihe nk'uko byagenda ku yindi miti. Ingaruka z'ubu buvuzi bw'iminsi 14 zishobora kumara imyaka myinshi mu bijyanye no gutinda gutangira indwara ya diyabete.
Nyuma yo kurangiza uburyo bwawe bwo kuvurwa, uzakenera gahunda zisanzwe zo gukurikirana kugira ngo ugenzure urugero rw'isukari mu maraso yawe n'ubuzima bwawe muri rusange. Muganga wawe azakurikirana uko umuti ukora neza binyuze mu kugenzura imikorere ya insuline yawe n'urugero rw'isukari mu maraso uko igihe kigenda gihita. Ibi bigenzurwa ni ngombwa kugira ngo hamenyekane niba kandi igihe ushobora gutangira izindi nshinge zo kuvura diyabete.
Kugeza ubu, nta buryo busanzwe bwo gusubiramo ubuvuzi bwa teplizumab. Ingaruka z'uyu muti zirashobora kumara igihe kirekire, kandi abashakashatsi baracyiga niba izindi nshinge zishobora kugirira akamaro abantu bamwe.
Kimwe n'indi miti yose, teplizumab ishobora gutera ingaruka, nubwo atari buri wese uzazibona. Ingaruka zisanzwe zikunze kuba zishobora gucungwa kandi akenshi zikagenda zikemuka uko umubiri wawe wimenyereza ubuvuzi.
Dore ingaruka zikunze kuvugwa cyane ushobora guhura nazo mu gihe cyangwa nyuma yo kuvurwa:
Ibyo bice byinshi by'ingaruka ni bike kugeza ku bice byinshi kandi bikemuka mu minsi mike kugeza ku byumweru nyuma yo kuvurwa. Itsinda ryawe ry'ubuvuzi rishobora gutanga imiti yo gufasha gucunga ibimenyetso nk'isesemi cyangwa umutwe bibayeho.
Hariho kandi ibindi bice bike ariko bikomeye by'ingaruka bisaba ubufasha bw'ubuvuzi bwihuse. Ibi bishoboka bidasanzwe birimo ibikorwa bikomeye by'uburwayi, indwara zikomeye ziterwa no gukandamiza ubudahangarwa, cyangwa impinduka zikomeye mu mubare w'uturemangingo tw'amaraso. Itsinda ryawe ry'ubuvuzi rizagukurikiranira hafi ibyo bishobora kuba.
Teplizumab ntibereye buri wese, ndetse no mu bantu bashobora kurwara diyabete ya 1. Ntugomba guhabwa uyu muti niba ufite allergie izwi kuri teplizumab cyangwa ibice byayo byose. Abantu bafite indwara zikora cyangwa ubudahangarwa bukomeye ntibakwiriye kuvurwa.
Muganga wawe azasuzuma neza amateka yawe y'ubuvuzi mbere yo kugusaba teplizumab. Ibyo bintu bimwe na bimwe bituma ubuvuzi butabereye cyangwa bisaba ingamba zidasanzwe:
Umutanga serivisi z'ubuzima nawe azatekereza ku myaka yawe, imiterere y'ubuzima bwawe muri rusange, n'indi miti urimo gufata. Bazagereranya inyungu zishoboka n'ibibazo kugira ngo bamenye niba teplizumab ikwiriye imiterere yawe yihariye.
Teplizumab icuruzwa ku izina rya Tzield. Iyi ni yo formulation imwe yemejwe na FDA ya teplizumab iriho muri Leta Zunze Ubumwe z'Amerika. Uyu muti ukorwa na Provention Bio kandi wemejwe na FDA mu Gushyingo 2022.
Igihe uvugana n'umuganga wawe cyangwa umufarimasi, ushobora kumva bavuga izina iryo ariryo ryose. Izina ryuzuye rya tekiniki ni teplizumab-mzwv, ariko abantu benshi barita Tzield cyangwa teplizumab.
Ubu, nta yindi miti yemejwe na FDA ishobora gutinda gutangira kwa diyabete yo mu bwoko bwa 1 nk'uko teplizumab ibishobora. Ibi bituma Tzield idasanzwe mu kuvura no gukumira diyabete. Ariko, abashakashatsi barimo gukora ubushakashatsi ku zindi nzira zishobora gukoreshwa mu gukumira.
Niba utemerewe gukoresha teplizumab cyangwa niba itagufitiye, umuganga wawe ashobora kuganira nawe ku zindi nzira zo gucunga ibyago bya diyabete yawe. Izi zirimo gukurikiranira hafi urugero rw'isukari mu maraso yawe, guhindura imibereho yawe, no kwitabira igeragezwa ryo mu bitaro ryo gupima imiti mishya yo gukumira.
Abantu bamwe bahitamo kwibanda ku gukurikiranira hafi no gukoresha insulin hakiri kare iyo diyabete imaze gutangira. Nubwo ibi bitakumira diyabete nk'uko teplizumab ibikora, bishobora gufasha kumenya iyi ndwara hakiri kare no gutangira kuyivura vuba.
Teplizumab ikora akazi gatandukanye rwose n'imiti isanzwe ivura diyabete, bityo kugereranya mu buryo butaziguye ntibishoboka. Mugihe imiti nka metformin cyangwa insulin ivura diyabete imaze kubaho, teplizumab igamije gukumira diyabete itaraba.
Uburyo uyu muti ukora neza bugomba gupimwa ugereranije no kutagira icyo ukora mu gukumira diyabete, atari ugereranije n'imiti ivura diyabete imaze kubaho. Mu igeragezwa ryo mu bitaro, teplizumab yatindije gutangira kwa diyabete yo mu bwoko bwa 1 ku kigereranyo cy'imyaka 2 ugereranije no kuvurwa na placebo.
Niba urwaye diyabete yo mu bwoko bwa 1, uzakenera imiti ya diyabete isanzwe nk'insuline. Teplizumab ntiyisimbuza iyi miti ahubwo itinda igihe uyikenera. Iyi ntambwe irashobora kuba ingirakamaro cyane mu kubungabunga ubuzima bwawe no kugabanya ingaruka zirambye za diyabete.
Teplizumab isaba kwitonderwa cyane niba ufite izindi ndwara ziterwa n'ubwirinzi bw'umubiri. Kubera ko uyu muti ugabanya imikorere y'ubwirinzi bw'umubiri, ushobora kugira ingaruka ku zindi ndwara ziterwa n'ubwirinzi bw'umubiri ushobora kuba ufite. Muganga wawe azakenera gusuzuma amateka yawe yose y'ubuzima n'imiti ukoresha ubu.
Niba ufite indwara nka rheumatoid arthritis, indwara yo mu gifu, cyangwa multiple sclerosis, ikipe yawe y'ubuzima izagereranya inyungu zo gukumira diyabete n'ibibazo byo kugira ingaruka ku zindi ndwara zawe. Bashobora gukenera guhindura imiti yawe cyangwa kongera gukurikiranwa mugihe cyo kuvurwa.
Niba ugize ingaruka zikomeye nko guhumeka nabi, ibimenyetso bikomeye byo kwivumbura, cyangwa ibimenyetso byo kwandura bikomeye, ugomba kwihutira gushaka ubufasha bw'ubuvuzi. Kubera ko wakira teplizumab mu kigo cy'ubuzima, abaganga bazaba bahari kugirango bafashe gucunga ibibazo byose bikomeye.
Ingaruka zoroheje nko kubabara umutwe, isesemi, cyangwa umuriro muke akenshi zishobora gucungwa no gufashwa. Ikipe yawe y'ubuzima irashobora gutanga imiti yo gufasha kuri ibi bimenyetso kandi izagukurikiranira hafi mugihe cyose cyo kuvurwa.
Kubera ko teplizumab itangwa nk'urukingo rucungwa muri serivisi z'ubuzima, gucikanwa urukingo biragabanuka ugereranije n'imiti ufata mu rugo. Ariko, niba ucikanwe urukingo rwatanzwe, vugana n'umuganga wawe ako kanya kugira ngo utegure urundi.
Igihe cyo gufata imiti yawe ni ingenzi kugira ngo imiti ikore neza. Itsinda ryawe ry'abaganga rizagena uburyo bwiza bwo gukomeza ubuvuzi bwawe niba ucikanwe urukingo, bishobora gusaba guhindura gahunda yawe cyangwa kongera igihe cy'ubuvuzi bwawe.
Teplizumab yateguwe nk'ubuvuzi bw'iminsi 14, nyuma yaho ubusanzwe uhagarika umuti. Bitandukanye n'imiti ikoreshwa igihe kirekire ufata iteka, teplizumab igamije gutanga inyungu zirambye kuva muri iki gihe gito cy'ubuvuzi.
Umuvuzi wawe azagenzura uko witwara ku buvuzi binyuze mu bipimo by'amaraso bisanzwe no gusuzumwa. Bazakurikiza uko umubiri wawe ukora insuline n'isukari mu maraso kugira ngo barebe uko umuti ukora neza. Ntabwo bizaba ngombwa ko ukomeza gufata teplizumab, ariko uzakenera kugenzurwa n'abaganga buri gihe.
Ugomba kwirinda inkingo zikora mu gihe uvurwa na teplizumab no mu byumweru byinshi nyuma yaho. Ibi birimo inkingo nk'urukingo rwa gripe rukora, MMR, n'inkingo za varicella. Ubudahangarwa bwawe buzahagarikwa by'agateganyo, bigatuma inkingo zikora zitaba umutekano.
Inkingo zitagira akamaro muri rusange zifite umutekano kurusha mu gihe cy'ubuvuzi, ariko umuganga wawe azatanga ubuyobozi bwihariye ku bijyanye n'inkingo ushobora guhabwa n'igihe. Birashoboka ko bazagusaba kuvugurura inkingo zawe mbere yo gutangira ubuvuzi bwa teplizumab niba bishoboka.
Get clear medical guidance
on symptoms, medications, and lab reports.
Download August today. No appointments. Just answers you can trust.